Successful treatment of anogenital lichen sclerosus with topical tacrolimus
- PMID: 12873890
- DOI: 10.1001/archderm.139.7.922
Successful treatment of anogenital lichen sclerosus with topical tacrolimus
Abstract
Background: Lichen sclerosus of the anogenital area is a chronic inflammatory and fibrosclerotic disease associated with substantial morbidity. Topical ultrapotent corticosteroids are currently the treatment of choice.
Observations: Three prepubertal girls and 3 adults (2 men, 1 woman) were treated with 0.1% tacrolimus ointment once daily. All patients experienced complete resolution with long-lasting remission for up to 1 year. No major adverse effects were observed, and treatment was well tolerated.
Conclusions: Topical tacrolimus is a promising novel agent in the treatment of lichen sclerosus of the anogenital area. A major advantage over topical corticosteroids is the lack of skin atrophy. Further clinical trials are warranted to confirm our findings.
Comment in
-
Topical tacrolimus, genital lichen sclerosus, and risk of squamous cell carcinoma.Arch Dermatol. 2004 Sep;140(9):1169. doi: 10.1001/archderm.140.9.1169-a. Arch Dermatol. 2004. PMID: 15381566 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
